The role of 1.5T cardiac MRI in the diagnosis, prognosis and management of pulmonary arterial hypertension

  • Gianluca MarroneEmail author
  • Giuseppe Mamone
  • Angelo Luca
  • Patrizio Vitulo
  • Alessandro Bertani
  • Michele Pilato
  • Bruno Gridelli


Cardiovascular magnetic imaging is a noninvasive, three dimensional tomographic technique that allows for a detailed morphology of the cardiac chambers, the accurate quantification of right ventricle volumes, myocardial mass, and transvalvular flow. It can also determine whether right ventricular diastolic function is impaired through pulmonary hypertension. The aim of this article is to review the main kinetic, morphological and functional changes of the right ventricle that can occur in patients affected by pulmonary arterial hypertension (PAH) and to assess how the MRI findings can influence the prognosis, and guide the decision-making strategy. In those cases in which MRI shows a significant cardiac diastolic dysfunction, the prognosis is predictive of pharmacological treatment failure, and mortality. This leaves double lung-heart transplantation as the only therapeutic option. The coexistence of PAH and left ventricle impairment causes worse right ventricle function, leads to a poor prognosis, and may change the therapeutic strategies (for example, PAH associated with left ventricle dysfunction may require a double lung-heart transplant).


Pulmonary arterial hypertension Cardiac magnetic resonance Dysfunction of the right ventricle Chronic thromboembolic pulmonary hypertension MR angiography Delayed enhancement 


  1. 1.
    McLure LE, Peacock AJ (2007) Imaging of the heart in pulmonary hypertension. Int J Clin Pract 61:15–26CrossRefGoogle Scholar
  2. 2.
    Chin KM, Rubin LJ (2008) Pulmonary arterial hypertension. JACC 16:1527–1538Google Scholar
  3. 3.
    Simonneau G, Galie N, Rubin LJ et al (2004) Clinical classification of pulmonary hypertension. J Am Coll Cardiol 43:5–12CrossRefGoogle Scholar
  4. 4.
    Ley S, Fink C, Zaporozhan J et al (2005) Value of high spatial, high temporal resolution magnetic resonance angiography for differentiation between idiopathic, thromboembolic pulmonary hypertension: initial results. Eur Radiol 15:2256–2263CrossRefPubMedGoogle Scholar
  5. 5.
    Nagendran J, Mickelakis E (2007) MRI. One-stop shop for the comprehensive assessment of pulmonary hypertension. Chest 132:2–5CrossRefPubMedGoogle Scholar
  6. 6.
    Coluden R (2006) State of the heart imaging techniques in chronic thromboembolic pulmonary hypertension. Proc Am Thoracic Soc 3:577–583CrossRefGoogle Scholar
  7. 7.
    Di Guglielmo L, Dore R, Vespro V (2005) Pulmonary Hypertension: role of computed tomography and magnetic resonance imaging. Ital Heart J 6:846–851PubMedGoogle Scholar
  8. 8.
    McCann G, Gan C, Beek A, Niessen HW, Vonk Noordegraaf A, Van Rossum AC (2007) Extent of MRI Delayed enhancement of myocardial mass is related to right ventricular dysfunction in pulmonary artery hypertension. AJR 188:349–354CrossRefPubMedGoogle Scholar
  9. 9.
    van Wolferen S, Marcus JT, Boonstra A et al (2007) Prognostic value of right ventricular mass, volume, and function in idiopathic pulmonary arterial hypertension. Eur Heart J 28:1250–1257CrossRefPubMedGoogle Scholar
  10. 10.
    Marcus JT, Vonk Noordegraaf A, Roeleved R et al (2001) Impaired left ventricular flling due to right ventricular pressure overload in primary pulmonary hypertension. Chest 119:1761–1765CrossRefPubMedGoogle Scholar
  11. 11.
    Roeleveld R, Marcus JT, Faes T et al (2005) Interventricular septal configuration at MR imaging, pulmonary arterial pressure in pulmonary hypertension. Radiology 234:710–717CrossRefPubMedGoogle Scholar
  12. 12.
    Dellegrottaglie S, Sanz J, Poon M et al (2007) Pulmonary hypertension: accuracy of detection with left ventricular septal-to-free-wall curvature ratio measured at cardiac MR. Radiology 243:63–69CrossRefPubMedGoogle Scholar
  13. 13.
    Kreitner K, Ley S, Kauczor HU et al (2004) Chronic thromboembolic pulmonary hypertension: pre- and postoperative assessment with breath-hold MR imaging techniques. Radiology 232:325–326CrossRefGoogle Scholar
  14. 14.
    Nikolaou K, Schoenberg S, Attenberger U et al (2005) Pulmonary arterial hypertension: diagnosis with fast perfusion MR imaging and high spatial resolution MR angiography preliminary experience. Radiology 236:694–703CrossRefPubMedGoogle Scholar
  15. 15.
    Beygui F, Furber A, Delepine S et al (2004) Routine breath-hold gradient echo MRI-derived right ventricular mass, volumes and function: accuracy, reproducibility and coherence study. Int J Cardiovasc Imaging 20:509–516CrossRefPubMedGoogle Scholar
  16. 16.
    Boxt L (1996) MR imaging of pulmonary hypertension, right ventricular dysfunction. Magn Reson Imaging Clin N Am 4:307–325PubMedGoogle Scholar
  17. 17.
    Lankhaar J, Westerhof N, Faes T et al (2006) Quantification of right ventricular afterload in patients with and without pulmonary hypertension. Am J Physiol Heart Circ Physiol 291:H1731–H1737CrossRefPubMedGoogle Scholar
  18. 18.
    Marcu C, Beek A, Van Rossum A (2006) Cardiovascular magnetic resonance imaging for the assessment of the right heart involvement in cardiac, pulmonary disease. Heart Lung Circ 15:362–370CrossRefPubMedGoogle Scholar
  19. 19.
    Sanz J, Kuschnir P, Rius T, Salguero Pulmonary R et al (2007) Hypertension: noninvasive detection with phase contrast MR imaging. Radiology 243:70–79CrossRefPubMedGoogle Scholar
  20. 20.
    Van Wolferen S, Marcus JT, Westerhof N et al (2008) Right coronary flow impairment in patients with pulmonary hypertension. Eur Heart J 29:120CrossRefPubMedGoogle Scholar
  21. 21.
    Kreitner K, Kunz R, Ley S et al (2007) Chronic thromboembolic pulmonary hypertension-assessment by magnetic resonance imaging. Eur Radiol 17:11–21CrossRefPubMedGoogle Scholar
  22. 22.
    Domenighetti G (2007) Prognosis, screening, early detection and differentiation of arterial pulmonary hypertension. Swiss Med WKLY 137:331–336PubMedGoogle Scholar
  23. 23.
    Kovacs G, Reiter G, Reiter U, Rienmuller R, Peacock A, Olschewski H (2008) The emerging role of magnetic resonance imaging in the diagnosis and management of pulmonary hypertension. Respiration 76:458–470CrossRefPubMedGoogle Scholar
  24. 24.
    Sanz J, Dellegrottaglie S, Kariisa M et al (2007) Prevalence and correlates of septal delayed contrast enhancement in patients with pulmonary hypertension. Am J Cardiol 100:731–735CrossRefPubMedGoogle Scholar
  25. 25.
    Blyth K, Groenning B, Martin T, Foster J (2005) Contrast enhanced-cardiovascular magnetic resonance imaging in patients with pulmonary hypertension. Eur Heart J 26:1993–1999CrossRefPubMedGoogle Scholar
  26. 26.
    Gan C, Holverda S, Marcus JT et al (2007) Right ventricular diastolic dysfunction, the acute effects of sidenafil in pulmonary hypertension patients. Chest 132:11–17CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, B.V. 2010

Authors and Affiliations

  • Gianluca Marrone
    • 1
    Email author
  • Giuseppe Mamone
    • 1
  • Angelo Luca
    • 1
  • Patrizio Vitulo
    • 2
  • Alessandro Bertani
    • 3
  • Michele Pilato
    • 4
  • Bruno Gridelli
    • 5
  1. 1.Diagnostic and Interventional Radiology, Mediterranean Institute of Transplantation and High Specialization Therapy (ISMETT)PalermoItaly
  2. 2.Pneumology, Mediterranean Institute of Transplantation and High Specialization Therapy (ISMETT)PalermoItaly
  3. 3.Thoracic Surgery, Mediterranean Institute of Transplantation and High Specialization Therapy (ISMETT)PalermoItaly
  4. 4.Cardiac Surgery, Mediterranean Institute of Transplantation and High Specialization Therapy (ISMETT)PalermoItaly
  5. 5.Abdominal and Thoracic Surgery, Mediterranean Institute of Transplantation and High Specialization Therapy (ISMETT)PalermoItaly

Personalised recommendations